Ukraine Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Ukraine Pharmaceuticals and Healthcare Report

Ukraine Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Ukraine Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
85 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued The aggressive expansion of generic drug firms could lead to badly needed foreign investment in domestic manufacturing. The introduction of a mandatory health insurance system in the medium-term will boost demand for innovative therapeutics and all pharmaceuticals Considerable unmet demand for modern treatments will remain for the foreseeable future, creating ongoing opportunities for multinationals to launch new products. ...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued The aggressive expansion of generic drug firms could lead to badly needed foreign investment in domestic manufacturing. The introduction of a mandatory health insurance system in the medium-term will boost demand for innovative therapeutics and all pharmaceuticals Considerable unmet demand for modern treatments will remain for the foreseeable future, creating ongoing opportunities for multinationals to launch new products. WTO accession and new reform agenda has led to the removal of tariffs on pharmaceuticals, lessened regulatory load on multinationals and added opportunities for importers. ...Geopolitical tension with Russia threatens civil stability. Foreign direct investment to remain subdued in relation to other comparable markets, on account of protectionist measures and similar factors.

...In June ----, Gilead Sciences filed a claim against the Ukrainian Drug Regulation Authority and the Ministry of Health alleging a breach of its patents for Sovaldi (sofosbuvir). It is challenging the right for Egyptian generic drugmaker, Pharco Pharmaceuticals, to supply a generic version of the hepatitis C medicine. ...The letter notes the organisation s serious concerns and strong opposition to Gilead s ongoing efforts to remove the only existing source of generic sofosbuvir in Ukraine . In March ----, GlaxoSmithKline altered its patent policy by eschewing its patents in low income countries as well as issuing licences to generic drugmakers for a royalty fee in lower-middle income countries. This is expected to benefit a number of countries, particularly Ukraine where there is currently a patent registered for the firm s HIV drug Tivicay (dolutegravir) and where the country s healthcare system is struggling to treat the large number of HIV-positive patients. ...In March ----, GlaxoSmithKline altered its patent policy by eschewing its patents in low income countries as well as issuing licences to generic drugmakers for a royalty fee in lower-middle income countries. This is expected to benefit a number of countries, particularly Ukraine where there is currently a patent registered for the firm s HIV drug Tivicay (dolutegravir) and where the country s healthcare system is struggling to treat the large number of HIV-positive patients.

...The introduction of a reference pricing mechanism and a simplified medicine registration system bodes well for the outlook of Ukraine s pharmaceutical market. In accordance with a draft bill by the Ministry of Health, which gained approval from Ukrainian parliament on -- May ----, the process of registration for medicines already approved abroad has been simplified. ...

  
Source:
Document ID
1748-2267
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Ukraine Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Ukraine-Pharmaceuticals-and-Healthcare-Report-2026-305>
  
APA:
Business Monitor International - Industry Reports. (2016). Ukraine Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Ukraine-Pharmaceuticals-and-Healthcare-Report-2026-305>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.